Medicamen Biotech Limited — Sulfamethoxazole Exporter Profile
Indian Pharmaceutical Exporter · #10 for Sulfamethoxazole · $442.8K export value · DGFT Verified
Medicamen Biotech Limited is the #10 Indian exporter of Sulfamethoxazole with $442.8K in export value and 18 verified shipments. Medicamen Biotech Limited holds a 2.2% market share in Sulfamethoxazole exports across 2 countries. The company exports 8 pharmaceutical products worth $5.3M across 6 therapeutic categories.
Medicamen Biotech Limited — Sulfamethoxazole Export Profile: Buyers & Destinations
Where Does Medicamen Biotech Limited Export Sulfamethoxazole?
| Country | Value | Shipments | Share |
|---|---|---|---|
| ETHIOPIA | $342.8K | 17 | 97.9% |
| KENYA | $7.5K | 1 | 2.1% |
Medicamen Biotech Limited exports Sulfamethoxazole to 2 countries. The largest destination is ETHIOPIA accounting for 97.9% of Medicamen Biotech Limited's Sulfamethoxazole shipments. These destinations reflect Medicamen Biotech Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Sulfamethoxazole from Medicamen Biotech Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER OF | ETHIOPIA | $174.0K | 9 |
| TO THE ORDER | ETHIOPIA | $106.0K | 7 |
| HIJRA BANK | ETHIOPIA | $38.3K | 1 |
| COMMERCIAL BANK OF ETHIOPIA | ETHIOPIA | $31.9K | 1 |
Medicamen Biotech Limited supplies Sulfamethoxazole to 4 buyers globally. The largest buyer is TO THE ORDER OF (ETHIOPIA), followed by TO THE ORDER (ETHIOPIA) and HIJRA BANK (ETHIOPIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Sulfamethoxazole Export Value and How Much Does Medicamen Biotech Limited Contribute?
India exported $12.2M worth of Sulfamethoxazole through 877 shipments from 145 suppliers to 92 countries, serving 266 buyers globally. Medicamen Biotech Limited contributes $442.8K to this total, accounting for 2.2% of India's Sulfamethoxazole exports. Medicamen Biotech Limited ships Sulfamethoxazole to 2 countries through 4 buyers.
What Is the Average Shipment Value for Medicamen Biotech Limited's Sulfamethoxazole Exports?
Medicamen Biotech Limited's average Sulfamethoxazole shipment value is $24.6K per consignment, based on 18 shipments totaling $442.8K. The largest destination is ETHIOPIA (97.9% of Medicamen Biotech Limited's Sulfamethoxazole exports).
How Does Medicamen Biotech Limited Compare to Other Indian Sulfamethoxazole Exporters?
Medicamen Biotech Limited ranks #10 among 145 Indian Sulfamethoxazole exporters with a 2.2% market share. The top 3 exporters are MICRO LABS LIMITED ($5.5M), FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED ($1.0M), AUROBINDO PHARMA LIMITED ($950.0K). Medicamen Biotech Limited processed 18 shipments to 2 destination countries.
What Sulfamethoxazole Formulations Does Medicamen Biotech Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PAEDIATRIC CO TRIMOXAZOLE ORAL SUSPENSION BP 240 MG 5 ML 100 ML Eh 5 ml cont Trimethoprim BP 40 mg Sulfamethoxazole BP | $50.0K | 1 |
| Paediatric Co-Trimoxazole Oral Suspension BP 240mg / 5 ml-100ML[Each 5 ml cont Trimethoprim BP- 40 mg,Sulfamethoxazole B | $50.0K | 1 |
| Paediatric Co-Trimoxazole Oral Suspension BP 240mg/5 ml/100 ML Each 5 ml contains:Trimethoprim BP-40 mg,Sulfamethoxazole | $38.3K | 1 |
| Paediatric Co-Trimoxazole Oral Suspension BP 240mg / 5 ml-100ml[Each 5 ml cont:Trimethoprim BP- 40 mg,Sulfamethoxazole B | $36.4K | 1 |
| PAEDIATRIC CO-TRIMOXAZOLE ORAL SUSPENSION BP 240MG / 5 ML EACH 5 ML CONTAINS:TRIMETHOPRIM BP- 40 MG,SULFAMETHOXAZOLE BP- | $36.0K | 3 |
| Paediatric Co-Trimoxazole Oral Suspension BP 240mg/5 ml 100 ML Each 5 ml contains:Trimethoprim BP-40 mg,Sulfamethoxazole | $31.9K | 1 |
| Paediatric Co-Trimoxazole Oral Suspension BP 240mg. 100ml.[Each 5 ml cont Trimethoprim BP- 40 mg,Sulfamethoxazole BP- 2 | $31.7K | 2 |
| PAEDIATRIC CO TRIMOXAZOLE ORAL SUSPENSION BP240MG 5ML Each 5 ml contains Trimethoprim BP 40 mg Sulfamethoxazole BP 200 | $22.4K | 1 |
| PAEDIATRIC CO TRIMOXAZOLE ORAL SUSPENSION BP240MG 5ML 100ML EH 5ML CONT Sulfamethoxazole BP 200mg Trimethoprim BP 40mg | $17.6K | 2 |
| PAEDIATRIC CO-TRIMOXAZOLE ORAL SUSPENSION BP 240MG / 5 ML-100ML[EACH 5 ML CONT TRIMETHOPRIM BP- 40 MG,SULFAMETHOXAZOLE BNOS | $16.0K | 3 |
Medicamen Biotech Limited exports 12 distinct Sulfamethoxazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PAEDIATRIC CO TRIMOXAZOLE ORAL SUSPENSION BP 240 MG 5 ML 100 with 1 shipments worth $50.0K.
How Does Medicamen Biotech Limited Compare to Nearest Sulfamethoxazole Exporters?
Exporters ranked immediately above and below #10 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | JODAS EXPOIM PRIVATE LIMITED | $481.8K | 21 | 1 | $22.9K |
| 9 | MEDREICH LIMITED | $454.4K | 20 | 1 | $22.7K |
| 10 | MEDICAMEN BIOTECH LIMITED ★ | $442.8K | 18 | 2 | $24.6K |
| 11 | CIPLA LIMITED | $404.2K | 38 | 6 | $10.6K |
| 12 | SYNCOM FORMULATIONS (INDIA) LIMITED | $395.8K | 43 | 5 | $9.2K |
Medicamen Biotech Limited ranks #10 among 145 Indian Sulfamethoxazole exporters. Average shipment value of $24.6K compared to the market average of $84.0K. The closest competitors by value are JODAS EXPOIM PRIVATE LIMITED and MEDREICH LIMITED.
Which Indian Ports Ship Sulfamethoxazole Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 85 | 9.7% |
| JNPT/ NHAVA SHEVA SEA | 83 | 9.5% |
| SAHAR AIR | 72 | 8.2% |
| JNPT | 65 | 7.4% |
| SAHAR AIR CARGO ACC (INBOM4) | 62 | 7.1% |
| PITHAMPUR ICD | 42 | 4.8% |
| APIIC PHARMA SEZ | 24 | 2.7% |
| NHAVA SHEVA | 24 | 2.7% |
What Other Advanced Antibiotics Products Does Medicamen Biotech Limited Export?
Medicamen Biotech Limited also exports these advanced antibiotics products. Each links to the detailed product page.
About Medicamen Biotech Limited
Medicamen Biotech Limited exports 8 products worth $5.3M. Beyond Sulfamethoxazole, top products include Folic, Trimethoprim, Nystatin, Diphenhydramine, Norfloxacin. View the complete Medicamen Biotech Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Sulfamethoxazole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Sulfamethoxazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Medicamen Biotech Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 18 individual customs records matching Medicamen Biotech Limited exporting Sulfamethoxazole, covering 12 formulations to 2 countries via 4 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 92+ countries, 266+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Sulfamethoxazole Export Data from Medicamen Biotech Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Medicamen Biotech Limited's Sulfamethoxazole exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Medicamen Biotech Limited
Full Company Profile →
8 products · $5.3M total trade · 6 categories
Sulfamethoxazole Stats
Company Overview
Top Products by Medicamen Biotech Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Medicamen Biotech Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Sulfamethoxazole. For current shipment-level data, contact TransData Nexus.